Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients

Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients

The main aim of this study was to identify the most relevant cytokines which, when assessed in the earliest stages from hospital admission, may help to select COVID-19 patients with worse prognosis. A retrospective observational study was conducted in 415 COVID-19 patients (272 males; mean age 68 ±...

Full description

Bibliographic Details
Main Authors: Martina Fabris, Fabio Del Ben, Emanuela Sozio, Antonio Paolo Beltrami, Adriana Cifù, Giacomo Bertolino, Federica Caponnetto, Marco Cotrufo, Carlo Tascini, Francesco Curcio
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:International Journal of Molecular Sciences
Subjects:
COVID-19
cytokine
proadrenomedullin
IL-6
IL-10
sIL2Rα
Online Access:https://www.mdpi.com/1422-0067/23/9/4830

Internet

https://www.mdpi.com/1422-0067/23/9/4830

Similar Items